SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-335251
Filing Date
2021-11-19
Accepted
2021-11-19 16:38:59
Documents
71
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d208378d10q.htm   iXBRL 10-Q 1520130
2 EX-31.1 d208378dex311.htm EX-31.1 11219
3 EX-31.2 d208378dex312.htm EX-31.2 11234
4 EX-32.1 d208378dex321.htm EX-32.1 3434
5 EX-32.2 d208378dex322.htm EX-32.2 3087
  Complete submission text file 0001193125-21-335251.txt   6755393

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crxt-20210930.xsd EX-101.SCH 74720
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crxt-20210930_cal.xml EX-101.CAL 39099
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crxt-20210930_def.xml EX-101.DEF 322778
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crxt-20210930_lab.xml EX-101.LAB 433586
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crxt-20210930_pre.xml EX-101.PRE 376988
11 EXTRACTED XBRL INSTANCE DOCUMENT d208378d10q_htm.xml XML 994802
Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39802 | Film No.: 211428854
SIC: 2836 Biological Products, (No Diagnostic Substances)